First Time Loading...

Evolus Inc
NASDAQ:EOLS

Watchlist Manager
Evolus Inc Logo
Evolus Inc
NASDAQ:EOLS
Watchlist
Price: 12.62 USD 7.22%
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

EOLS Price Targets Summary
Evolus Inc

Wall Street analysts forecast EOLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EOLS is 22.73 USD with a low forecast of 16.16 USD and a high forecast of 28.35 USD.

EOLS Lowest Forecast
Wall Street Target
16.16 USD
28% Upside
EOLS Average Forecast
Wall Street Target
22.73 USD
80% Upside
EOLS Highest Forecast
Wall Street Target
28.35 USD
125% Upside
Lowest
Price Target
16.16 USD
28% Upside
Average
Price Target
22.73 USD
80% Upside
Highest
Price Target
28.35 USD
125% Upside
Evolus Inc Competitors:
Price Targets
F
FAE
Faes Farma SA
17% Upside
M
600993
Mayinglong Pharmaceutical Group Co Ltd
27% Downside
D
170900
Dong-A ST Co Ltd
29% Upside
P
PLTH
Planet 13 Holdings Inc
169% Upside
F
FAE
Faes Farma SA
17% Upside
M
600993
Mayinglong Pharmaceutical Group Co Ltd
27% Downside
D
170900
Dong-A ST Co Ltd
29% Upside
P
PLTH
Planet 13 Holdings Inc
169% Upside
A
ASRT
Assertio Holdings Inc
232% Upside
M
MEGA
Mega Lifesciences PCL
22% Upside
OFSA3
Ouro Fino Saude Animal Participacoes SA
13% Upside
COLL
Collegium Pharmaceutical Inc
8% Upside

Revenue
Forecast

Revenue Estimate
Evolus Inc

The compound annual growth rate of Evolus Inc's revenue for the next 3 years is 31%.

N/A
Past Growth
31%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Evolus Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
16%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Evolus Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
What are analyst estimates?

See Also

Summary
EOLS intrinsic value, competitors valuation, and company profile.
DCF Valuation
EOLS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EOLS stock valuation using valuation multiples.
Wall Street Estimates
EOLS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EOLS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EOLS's stock price target?
Price Target
22.73 USD

According to Wall Street analysts, the average 1-year price target for EOLS is 22.73 USD with a low forecast of 16.16 USD and a high forecast of 28.35 USD.

What is Evolus Inc's Revenue forecast?
Projected CAGR
31%

The compound annual growth rate of Evolus Inc's revenue for the next 3 years is 31%.

ALPHA SPREAD
Join more than 133,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.